GlassScriptPhysician profile
Melody L Strattan
NPI 1487934097
$9,301.39
in general payments reported to CMS, 2019-2025
39 companies · $1,497 in 2025
The $1,497 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $650 · 2021: $1,183 · 2022: $1,897 · 2023: $1,715 · 2024: $1,721 · 2025: $1,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,932.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,402.74 | 2019-2025 | Mitraclip, Navitor, Gallant |
| Merck Sharp & Dohme LLC | $663.78 | 2021-2025 | Verquvo, Capvaxive |
| Boston Scientific Corporation | $656.02 | 2019-2025 | Watchman Flx, S-Icd System Magnet |
| Novartis Pharmaceuticals Corporation | $567.93 | 2019-2025 | |
| Amgen INC. | $560.28 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $493.01 | 2019-2024 | Xarelto |
| Pfizer INC. | $374.72 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $364.63 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $360.63 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $283.24 | 2022-2025 | Onpattro |
| Philips North America LLC | $230.16 | 2022-2025 | Event, (Br5) Peripheral Ivus, (Ck7) Extended Holter |
| Medtronic, INC. | $215.08 | 2021-2023 | Micra |
| Astellas Pharma US INC | $199.05 | 2019-2020 | |
| Esperion Therapeutics, INC. | $197.18 | 2021-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $190.51 | 2019-2024 | Farxiga |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $170.62 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.02 | 2019-2025 | Jardiance |
| Becton, Dickinson and Company | $132.63 | 2023 | Rotarexs 6 F X 135 Cm |
| Sanofi-Aventis U.S. LLC | $129.19 | 2021-2023 | |
| Biotronik INC. | $123.02 | 2023-2024 | Biomonitor |
| Scpharmaceuticals INC. | $120.77 | 2024-2025 | |
| Abiomed | $97.77 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $69.74 | 2019-2024 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $60.21 | 2023-2024 | Inpefa |
| Terumo Medical Corporation | $59.76 | 2019-2022 | |
| Chiesi USA, INC. | $59.17 | 2019-2022 | |
| Cardiva Medical, INC. | $51.28 | 2024 | Optowire, Savvywire |
| Cvrx, INC. | $48.63 | 2025 | Barostim Neo System |
| Amarin Pharma, INC. | $43.98 | 2020-2021 | |
| Irhythm Technologies, INC. | $36.47 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Inspire Medical Systems, INC. | $32.65 | 2025 | Inspire |
| Angiodynamics, INC. | $31.59 | 2022 | |
| Cardiovascular Systems INC. | $24.19 | 2020 | |
| Kestra Medical Technology Services, INC. | $21.16 | 2023 | Assure Wcd |
| Stryker Corporation | $20.06 | 2025 | Artix Mt |
| Novo Nordisk INC | $18.57 | 2024 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $18.47 | 2024 | Arcalyst |
| Innovation Technologies INC | $15.47 | 2021 | |
| Amryt Pharma Holdings LTD | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Strattan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.